Understanding the psychological aspects of the radicalisation process: a sociocognitive approach

por Garcet, Serge
Publicado 2021

Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis

por Krueger, James G., Murrell, Dedee F., Garcet, Sandra, Navrazhina, Kristina, Lee, Patricia C., Muscianisi, Elisa, Blauvelt, Andrew
Publicado 2021

A shared tissue transcriptome signature and pathways in psoriasis and ulcerative colitis

por Xi, Li, Garcet, Sandra, Ye, Zhan, Hung, Kenneth, Hassan-Zahraee, Mina, Kieras, Elizabeth, Krueger, James G., Hyde, Craig, Peeva, Elena
Publicado 2022

Guselkumab More Effectively Neutralizes Psoriasis-Associated Histologic, Transcriptomic, and Clinical Measures than Ustekinumab

por Campbell, Kim, Li, Katherine, Yang, Feifei, Branigan, Patrick, Elloso, M. Merle, Benson, Jacqueline, Orlovsky, Yevgeniya, Chen, Yanqing, Garcet, Sandra, Krueger, James G.
Publicado 2023

Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin

por Kim, Jaehwan, Lee, Jongmi, Li, Xuan, Kunjravia, Norma, Rambhia, Darshna, Cueto, Inna, Kim, Katherine, Chaparala, Vasuma, Ko, Younhee, Garcet, Sandra, Zhou, Wei, Cao, Junyue, Krueger, James G.
Publicado 2023

Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways

por Tollenaere, M.A.X., Hebsgaard, J., Ewald, D.A., Lovato, P., Garcet, S., Li, X., Pilger, S.D., Tiirikainen, M.L., Bertelsen, M., Krueger, J.G., Norsgaard, H.
Publicado 2021

Obesity and ethnicity alter gene expression in skin

por Walker, Jeanne M., Garcet, Sandra, Aleman, Jose O., Mason, Christopher E., Danko, David, Butler, Daniel, Zuffa, Simone, Swann, Jonathan R., Krueger, James, Breslow, Jan L., Holt, Peter R.
Publicado 2020

Author Correction: Obesity and ethnicity alter gene expression in skin

por Walker, Jeanne M., Garcet, Sandra, Aleman, Jose O., Mason, Christopher E., Danko, David, Butler, Daniel, Zuffa, Simone, Swann, Jonathan R., Krueger, James, Breslow, Jan L., Holt, Peter R.
Publicado 2021

Bimekizumab for the treatment of moderate‐to‐severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double‐...

por Oliver, R., Krueger, J.G., Glatt, S., Vajjah, P., Mistry, C., Page, M., Edwards, H., Garcet, S., Li, X., Dizier, B., Maroof, A., Watling, M., el Baghdady, A., Baeten, D., Ionescu, L., Shaw, S.
Publicado 2021

A phase I, randomized, double‐blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate pla...

por Berstein, G., Zhang, Y., Berger, Z., Kieras, E., Li, G., Samuel, A., Yeoh, T., Dowty, H., Beaumont, K., Wigger‐Alberti, W., von Mackensen, Y., Kroencke, U., Hamscho, R., Garcet, S., Krueger, J. G., Banfield, C., Oemar, B.
Publicado 2020

The erythema Q‐score, an imaging biomarker for redness in skin inflammation

por Frew, John, Penzi, Lauren, Suarez‐Farinas, Mayte, Garcet, Sandra, Brunner, Patrick M., Czarnowicki, Tali, Kim, Jaehwan, Bottomley, Claire, Finney, Robert, Cueto, Inna, Fuentes‐Duculan, Judilyn, Ohmatsu, Hanako, Lentini, Tim, Yanofsky, Valerie, Krueger, James G., Guttman‐Yassky, Emma, Gareau, Daniel
Publicado 2020

Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial

por Harris, Kristina M., Smilek, Dawn E., Byron, Margie, Lim, Noha, Barry, William T., McNamara, James, Garcet, Sandra, Konrad, Robert J., Stengelin, Martin, Bathala, Pradeepthi, Korman, Neil J., Feldman, Steven R., Boh, Erin E., Barber, Kirk, Laumann, Anne E., Helfrich, Yolanda Rosi, Krueger, Gerald G., Sofen, Howard, Bissonnette, Robert, Krueger, James G.
Publicado 2021